In organophosphate poisoning, which of the following antidotes acts by reactivating acetylcholinesterase if administered within the critical 'oxime window'?

Explanation

## Oxime Reactivation in Organophosphate Poisoning ### The Oxime Window Concept **Key Point:** Oximes (pralidoxime, obidoxime) can reactivate acetylcholinesterase ONLY if administered before "aging" of the phosphorylated enzyme complex occurs. This window is typically 24–48 hours, depending on the specific organophosphate. ### Mechanism of Pralidoxime (2-PAM) 1. Oxime nucleophilically attacks the phosphorus atom 2. Phosphate group is removed from serine residue 3. Native AChE enzyme is regenerated and becomes functional again 4. Acetylcholine hydrolysis resumes **High-Yield:** Once "aging" occurs (loss of an alkyl group from the phosphate), the enzyme-toxin complex becomes irreversible and oximes are ineffective. ### Comparison of Antidotes | Antidote | Mechanism | Role | Timing | |----------|-----------|------|--------| | **Pralidoxime (2-PAM)** | Nucleophilic attack on phosphorus; reactivates AChE | Specific reactivator | Within 24–48 hrs (oxime window) | | **Atropine** | Competitive antagonist at muscarinic receptors | Symptomatic relief only; blocks muscarinic effects | Any time; does NOT reactivate enzyme | | **Physostigmine** | Cholinesterase inhibitor | Contraindicated in organophosphate poisoning; worsens toxicity | Avoid | | **Neostigmine** | Cholinesterase inhibitor | Contraindicated in organophosphate poisoning; worsens toxicity | Avoid | ### Clinical Management Algorithm ```mermaid flowchart TD A[Organophosphate Exposure]:::outcome --> B{Time since exposure?}:::decision B -->|< 24-48 hours| C[Pralidoxime + Atropine]:::action B -->|> 48 hours| D[Atropine only]:::action C --> E[AChE reactivation + symptom relief]:::outcome D --> F[Symptom relief only]:::outcome ``` **Clinical Pearl:** Pralidoxime is most effective when combined with atropine. Atropine blocks muscarinic effects (miosis, bronchospasm, bradycardia) while pralidoxime reactivates the enzyme. Nicotinic effects (muscle weakness, fasciculations) respond better to pralidoxime than atropine. **Warning:** Delayed administration of pralidoxime beyond the oxime window (aging has occurred) renders it ineffective. Early recognition and treatment are critical.